Literature DB >> 8790414

On the etiology of Crohn disease.

D Mishina1, P Katsel, S T Brown, E C Gilberts, R J Greenstein.   

Abstract

Crohn disease (CD) is a chronic, panenteric intestinal inflammatory disease. Its etiology is unknown. Analogous to the tuberculoid and lepromatous forms of leprosy, CD may have two clinical manifestations. One is aggressive and fistulizing (perforating), and the other is contained, indolent, and obstructive (nonperforating) [Gi]-berts, E. C. A. M., Greenstein, A. J., Katsel, P., Harpaz, N. & Greenstein, R. J. (1994) Proc. Natl. Acad. Sci. USA 91, 12721-127241. The etiology, if infections, may be due to Mycobacterium paratuberculosis. We employed reverse transcription PCR using M. paratuberculosis subspecies-specific primers (IS 900) on total RNA from 12 ileal mucosal specimens (CD, n = 8; controls, n = 4, 2 with ulcerative colitis and 2 with colonic cancer). As a negative control, we used Myobacterium avium DNA, originally cultured from the drinking water of a major city in the United States. cDNA sequence analysis shows that all eight cases of Crohn's disease and both samples from the patients with ulcerative colitis contained M. paratuberculosis RNA. Additionally, the M. avium control has the DNA sequence of M. paratuberculosis. We demonstrate the DNA sequence of M. paratuberculosis from mucosal specimens from humans with CD. The potable water supply may be a reservoir of infection. Although M. paratuberculosis signal in CD has been previously reported, a cause and effect relationship has not been established. In part, this is due to conflicting data from studies with empirical antimycobacterial therapy. We conclude that clinical trials with anti-M. paratuberculosis therapy are indicated in patients with CD who have been stratified into the aggressive (perforating) and contained (nonperforating) forms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790414      PMCID: PMC38512          DOI: 10.1073/pnas.93.18.9816

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Molecular Koch's postulates applied to microbial pathogenicity.

Authors:  S Falkow
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

2.  Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery.

Authors:  P J McDonald; V W Fazio; R G Farmer; D G Jagelman; I C Lavery; W B Ruderman; K A Easley; P H Harper
Journal:  Dis Colon Rectum       Date:  1989-02       Impact factor: 4.585

3.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

4.  Corticosteroids and corticotrophin in the treatment of Crohn's disease.

Authors:  J H Jones; J E Lennard-Jones
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

5.  Crohn's disease. Rifampin treatment of the ocular and gut disease.

Authors:  E Wirostko; L Johnson; B Wirostko
Journal:  Hepatogastroenterology       Date:  1987-04

6.  Remission of Crohn's disease with tuberculosis chemotherapy.

Authors:  J B Warren; H C Rees; T M Cox
Journal:  N Engl J Med       Date:  1986-01-16       Impact factor: 91.245

7.  Remission of Crohn's disease with antimycobacterial chemotherapy.

Authors:  M G Schultz; H L Rieder; T Hersh; S Riepe
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

8.  Controlled trial of rifampicin and ethambutol in Crohn's disease.

Authors:  J L Shaffer; S Hughes; B D Linaker; R D Baker; L A Turnberg
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

9.  Mycobacteria in the intestine of Japanese patients with inflammatory bowel disease.

Authors:  K Suenaga; Y Yokoyama; K Okazaki; Y Yamamoto
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

10.  Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species.

Authors:  J J McFadden; P D Butcher; R Chiodini; J Hermon-Taylor
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

View more
  40 in total

Review 1.  Is Mycobacterium avium subsp. paratuberculosis, the cause of Johne's disease in animals, a good candidate for Crohn's disease in man?

Authors:  A V Singh; S V Singh; P K Singh; J S Sohal
Journal:  Indian J Gastroenterol       Date:  2010-05-05

Review 2.  Leprosy as a genetic disease.

Authors:  Andrea Alter; Audrey Grant; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  Mamm Genome       Date:  2010-10-09       Impact factor: 2.957

3.  Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model.

Authors:  Ugur Duman; Aysun Yilmazlar; Ersin Ozturk; Sibel Aker; Emre Sarandol; Tuncay Yilmazlar
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

4.  Survival of Mycobacterium avium subsp. paratuberculosis in dam water and sediment.

Authors:  Richard J Whittington; Ian B Marsh; Leslie A Reddacliff
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 5.  Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease?

Authors:  R Balfour Sartor
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues.

Authors:  Jay L E Ellingson; John C Cheville; Dominique Brees; Janice M Miller; Norman F Cheville
Journal:  Clin Med Res       Date:  2003-07

7.  Growth, Congo Red agar colony morphotypes and antibiotic susceptibility testing of Mycobacterium avium subspecies paratuberculosis.

Authors:  Nicole M Parrish; Chiew G Ko; James D Dick; Paul B Jones; Jay L E Ellingson
Journal:  Clin Med Res       Date:  2004-05

8.  Cellular infiltration and cytokine expression correlate with fistulizing state in Crohn's disease.

Authors:  Saleh A Naser; Claudia Romero; Princess Urbina; Najih Naser; John Valentine
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

9.  Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours.

Authors:  Emma C Stanley; Richard J Mole; Rebecca J Smith; Sarah M Glenn; Michael R Barer; Michael McGowan; Catherine E D Rees
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

Review 10.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.